Division of Human Genetics, Departments of Paediatrics and Clinical Research, University of Bern, Bern, Switzerland.
J Med Genet. 2014 Mar;51(3):170-5. doi: 10.1136/jmedgenet-2013-101932. Epub 2013 Dec 23.
Defects of the mitochondrial respiratory chain complex II (succinate dehydrogenase (SDH) complex) are extremely rare. Of the four nuclear encoded proteins composing complex II, only mutations in the 70 kDa flavoprotein (SDHA) and the recently identified complex II assembly factor (SDHAF1) have been found to be causative for mitochondrial respiratory chain diseases. Mutations in the other three subunits (SDHB, SDHC, SDHD) and the second assembly factor (SDHAF2) have so far only been associated with hereditary paragangliomas and phaeochromocytomas. Recessive germline mutations in SDHB have recently been associated with complex II deficiency and leukodystrophy in one patient.
We present the clinical and molecular investigations of the first patient with biochemical evidence of a severe isolated complex II deficiency due to compound heterozygous SDHD gene mutations. The patient presented with early progressive encephalomyopathy due to compound heterozygous p.E69 K and p.164Lext3 SDHD mutations. Native polyacrylamide gel electrophoresis and western blotting demonstrated an impaired complex II assembly. Complementation of a patient cell line additionally supported the pathogenicity of the novel identified mutations in SDHD.
This report describes the first case of isolated complex II deficiency due to recessive SDHD germline mutations. We therefore recommend screening for all SDH genes in isolated complex II deficiencies. It further emphasises the importance of appropriate genetic counselling to the family with regard to SDHD mutations and their role in tumorigenesis.
线粒体呼吸链复合物 II(琥珀酸脱氢酶(SDH)复合物)的缺陷极为罕见。在组成复合物 II 的四个核编码蛋白中,只有 70 kDa 黄素蛋白(SDHA)和最近发现的复合物 II 组装因子(SDHAF1)的突变被认为是导致线粒体呼吸链疾病的原因。其他三个亚基(SDHB、SDHC 和 SDHD)和第二个组装因子(SDHAF2)的突变迄今仅与遗传性副神经节瘤和嗜铬细胞瘤有关。SDHB 种系隐性突变最近与一名患者的复合物 II 缺乏症和白质营养不良有关。
我们介绍了首例具有生化证据的严重孤立性复合物 II 缺乏症患者的临床和分子研究,该患者由于复合杂合性 SDHD 基因突变。该患者由于复合杂合性 p.E69 K 和 p.164Lext3 SDHD 突变而出现早期进行性脑病。天然聚丙烯酰胺凝胶电泳和 Western blot 表明复合物 II 组装受损。患者细胞系的互补进一步支持了 SDHD 中新型鉴定突变的致病性。
本报告描述了首例由于隐性 SDHD 种系突变导致的孤立性复合物 II 缺乏症。因此,我们建议在孤立性复合物 II 缺乏症中筛查所有 SDH 基因。它进一步强调了对家族进行适当遗传咨询的重要性,涉及 SDHD 突变及其在肿瘤发生中的作用。